US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

63.69

+1.292.06%

Volume:7K

Turnover:457.29K

Market Cap:275.12M

PE:20.83

High:63.75

Open:63.03

Low:63.03

Close:62.40

52wk High:64.10

52wk Low:39.10

Shares:4.32M

Float Shares:4.32M

Volume Ratio:0.61

T/O Rate:0.17%

Dividend:1.53

Dividend Rate:2.40%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Alphabet Inc. Cuts Share Stake in Revolution Medicines Inc by 10.5% to 2.9 Mln Shares - SEC Filing

THOMSON REUTERS

8 ‘trendsetter’ stocks for world’s top mega-trends: Jon Erlichman

Roivant Sciences Ltd : TD Cowen Raises Target Price to $50 from $41

THOMSON REUTERS

Dual Focus on Innovation and Global Expansion Drives Medical Device Sector Upgrades - ETF Tool Supports Recovery Opportunities

Wall Street Analysts Are Bullish on Top Healthcare Picks

Bernstein Remains a Hold on Revolution Medicines (RVMD)

Roivant Sciences Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Immunovant, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Analysts Have Conflicting Sentiments on These Healthcare Companies: Revolution Medicines (RVMD), Royalty Pharma (RPRX) and Urogen Pharma (URGN)

Roivant Sciences' Fiscal Q1 Net Loss Narrows, Revenue Declines

MT Newswires Live

Immunovant FY27 Q1 Net Loss Widens 27% to $153.2 Million; R&D Expenses Rise 40.9% to $142.6 Million

Roivant Sciences Q1 Adj. EPS $(0.34) Misses $(0.32) Estimate, Sales $1.442M Miss $2.057M Estimate

Benzinga Earnings

Roivant Unit Priovant Begins Phase 3 Beacon+ Trial of Brepocitinib in Cutaneous Sarcoidosis

Roivant Q1 FY27 Net Loss Widens to $290.61 Million; Revenue Slips to $1.44 Million

Roivant Sciences Q1 Adjusted Net Income USD -290.606 Million Vs. IBES Estimate USD -192.3 Million

Roivant Sciences - Brepocitinib Nda Approval and Launch in Dermatomyositis Expected by End of September 2026

THOMSON REUTERS

Revolution Medicines, Inc. : Needham Raises Target Price to $240 from $236

THOMSON REUTERS

Revolution Medicines Publishes Corporate Deck Outlining Ras(on) Inhibitor Pipeline Targeting RAS-Driven Cancers

Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million

Revolution Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PTH/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":63.685,"timestamp":1787673018224,"preClose":62.3981,"halted":0,"volume":7197,"delay":0,"changeRate":0.02062402541103019,"floatShares":4320000,"shares":4320000,"eps":3.057033,"marketStatus":"Trading","change":1.2869,"latestTime":"08-25 11:50:56 EDT","open":63.03,"high":63.75,"low":63.03,"amount":457291.730355,"amplitude":0.011539,"askPrice":63.6,"askSize":800,"bidPrice":63.48,"bidSize":225,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":62.3981,"sharesOutstanding":2480000,"nav":62.98271,"aum":273974788.5,"dividendRate":0.024006,"bidAskSpread":0.002049,"postHourTrading":{"tag":"盘后","latestPrice":62.41,"preClose":62.3981,"latestTime":"19:30 EDT","volume":14,"amount":872.8867,"timestamp":1787614203296,"change":0.0119,"changeRate":0.000191,"amplitude":0},"volumeRatio":0.605134,"impliedVol":0.1604,"impliedVolPercentile":0.7928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4320000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.605134,"shares":4320000,"dividePrice":1.5288,"high":63.75,"amplitude":0.011539,"preClose":62.3981,"low":63.03,"week52Low":39.1,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":63.685,"committee":-0.560976,"eps":3.057033,"divideRate":0.024006,"volume":7197,"delay":0,"ttmEps":3.057033,"open":63.03,"prevYearClose":49.701,"prevWeekClose":62.9761,"prevMonthClose":58.0963,"prevQuarterClose":59.76,"fiveDayClose":60.7585,"twentyDayClose":57.983,"sixtyDayClose":51.9608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657147906","title":"Alphabet Inc. Cuts Share Stake in Revolution Medicines Inc by 10.5% to 2.9 Mln Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657147906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657147906?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:02","pubTimestamp":1786096957,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN4432E1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0225283273.USD","IE00BJT1NW94.SGD","IE00BJTD4N35.SGD","LU0061474960.USD","SG9999015986.USD","SGXZ81514606.USD","SG9999018865.SGD","LU1235294995.USD","LU0320765992.SGD","LTL","LU1059921491.USD","LU0203347892.USD","LU0444973449.USD","LU0942090050.USD","LU0097036916.USD","LU0323591593.USD","CQTM","LU1003077747.HKD","LU1935043536.SGD","LU0348723411.USD","LU1046421795.USD","LU1221951129.SGD","IE00B7SZLL34.SGD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU2275660780.HKD","LU2097344431.USD","GB00B4LPDJ14.GBP","LU0494093205.USD","IE00BKPKM429.USD","BK4598","LU0342679015.USD","LU0314106906.USD","LU2028103732.USD","LU0138981039.USD","LU0690374961.EUR","LU1084165304.USD","LU0784385840.USD","IE00BBT3K403.USD","LU2362541513.USD","LU0477156953.USD","LU1720051108.HKD","LU0985320562.USD","BK4538","LU0211326755.USD","LU1316542783.SGD","GOU","LU0882574139.USD","LU2250418816.HKD","LU0466842654.USD","LU0174119429.USD","IE000BZT7R73.USD","LU0868494708.USD","GGLL","LU1868836591.USD","LU2247934214.USD","RVMD","LU2505996681.GBP","LU0648001328.SGD","LU1551013342.USD","LU1914381329.SGD","LU0345770993.USD","LU0353189680.USD","IE00B19Z9505.USD","IE00BFMHRM44.USD","LU0964807845.USD","LU2420271590.USD","GGLS","LU2326559502.SGD","LU1989772923.USD","LU0444971666.USD","LU2111349929.HKD","GB00B4QBRK32.GBP","LU0154236417.USD","LU1670628061.USD","LU1974910355.USD","SG9999014914.USD","SG9999014906.USD","LU1571399168.USD","LU1435385759.SGD","IE00B2B36J28.USD","LU0889565916.HKD","LU2430703178.SGD","LU0496365809.HKD","LU2242649171.HKD","FCOM","LU1718418525.SGD","HK0000819398.USD","LU0029864427.USD","LU0187121727.USD","LU2404859667.USD","LU1280957306.USD","LU1064131342.USD","LU1244550221.USD","LU1429558221.USD","SG9999017495.SGD","LU0557290698.USD","LU2063271972.USD","LU1201861249.SGD","LU2491050154.USD","LU2360032135.SGD","LU2125154778.USD","LU0820562030.AUD","LU2381873111.SGD","LU0784383803.USD","LU0011850046.USD","LU0170899867.USD","SGXZ44715902.SGD","LU0251142724.SGD","LU1261432733.SGD","LU1674673428.USD","IE00BQXX3C00.GBP","LU0048573561.USD","LU1868837136.USD","LU2089284900.SGD","LU0661504455.SGD","BK4561","BK4503","BK4532","LU1066051225.USD","LU1645745479.HKD","LU2242650005.HKD","BK4585","LU1804176565.USD","LU2191332357.HKD","IE0009354923.USD","IE000F7OJYX1.SGD","LU0976567544.SGD","SG9999014898.SGD","LU1548497426.USD","IE00BKVL7J92.USD","LU1935042488.USD","LU2168564495.EUR","BK4550","SNPE","LU0949170772.SGD","LU2098885051.SGD","IE00BZ1G4Q59.USD","IE00BD6J9T35.USD","LU0124676726.USD","IE00B19Z3581.USD","SG9999014575.USD","LU2433249047.HKD","LU0823434740.USD","IE00BKDWB100.SGD","LU2430703095.HKD","IE00BK4W5L77.USD","CMAG","LU2357305700.SGD","IE0002141913.USD","LU2125909593.SGD","SG9999014567.USD","LU1880398471.USD","LU0080751232.USD","LU1642822529.SGD","IE0034235303.USD","LU1043141396.HKD","LU2168564149.EUR","LU0472753341.HKD","LU0256863811.USD","IE00BDCRKT87.USD","LU2087621335.USD","LU2213496289.HKD","LU1791710400.SGD","LU0345768740.USD","LU0784385170.HKD","LU1551013425.SGD","LU1032955483.USD","LU2065169927.USD","SG9999015952.SGD","LU0477156797.USD","LU0094547139.USD","LU0426417589.USD","LU0251132253.USD","LU0302445910.USD","LU1699723380.USD","IE0034235188.USD","LU0106261372.USD","SG9999015978.USD","LU0345768153.USD","SGXZ51526630.SGD","IE00BSNM7G36.USD","LU0823434583.USD","LU0130517989.USD","LU1894683348.USD","LU1116320901.HKD","LU1935043023.USD","BK4579","GOOP","BK4576","LU0980610538.SGD","LU1267930490.SGD","BK4573","LU0640476718.USD","LU1633808545.USD","BK4574","LU1791710582.SGD","IE00B19Z8X17.USD","LU2023250843.SGD","LU0820561909.HKD","LU1815333072.USD","LU0683600562.USD","LU1880398554.USD","LU0234572021.USD","LU0289961442.SGD","SG9999014542.SGD","LU1267930227.SGD","LU1232071149.USD","LU0234570918.USD","LU1202635105.USD","CANC","GOOX","LU1868836914.USD","LU1196500208.SGD","LU1496350171.SGD","LU0256863902.USD","LU2089283258.USD","XLC","LU0056508442.USD","IE0004091025.USD","LU0957791311.USD","LU0320765489.SGD","LU1506573853.SGD","IDNA","IE00BHPRN162.USD","SG9999015358.SGD","LU0689472784.USD","HK0000914660.USD","LU0211326839.USD","LU2265009873.SGD","LU1366192091.USD","LU1303367103.USD","LU2417539215.USD","LU1989764664.SGD","LU0006306889.USD","LU1839511570.USD","LU1066051811.HKD","IE00BQXX3D17.EUR","LU2092627202.USD","LU0742534661.SGD","LU0949170426.SGD","LU0314104364.USD","LU0130103400.USD","IE000MB6IJN5.SGD","LU0787776722.HKD","LU0251131958.USD","SG9999000418.SGD","BK4533","LU2750360997.AUD","LU2106854487.HKD","LU1674673691.USD","LU2236285917.USD","TRUC","IE00BDRTCR15.USD","LU0203345920.USD","LU0708994859.HKD","SG9999015945.SGD","LU2471134952.CNY","LU1116320737.USD","LU0208291251.USD","LU0672654240.SGD","LU1951200564.SGD","LU0061474705.USD","LU1935042991.SGD","LU1066051498.USD","IE00BLSP4239.USD","LU2244417387.USD","LU2023250504.SGD","LU0310799852.SGD","LU0265550946.USD","LU1400636657.SGD","LU0823421416.USD","LU1894683264.USD","LU1923623000.USD","LU0738911758.USD","LU2023251221.USD","LU2505996509.AUD","LU0057025933.USD","LU2125909247.SGD","LU2430703251.USD","OGIG","LU0289739343.SGD","LU2404859741.USD","LU1301847155.USD","LU0198837287.USD","LU2954938101.SGD","LU1119994496.HKD","LU2125154935.USD","LU0312595415.SGD","IE00BMPRXN33.USD","LU2462591277.SGD","LU1803068623.USD","LU0868494617.USD","HK0000914686.HKD","IE00B19Z8W00.USD","IE00BWXC8680.SGD","LU0211331839.USD","LU0417517546.SGD","LU0553294199.USD","IE00BQXX3F31.USD","LU1629891620.HKD","LU1267930573.SGD","LU0061475181.USD","SKYY","GOOGL","LU2592432038.USD","LU0943347566.SGD","IE0034235295.USD","LU0107464264.USD","LU0289960550.SGD","HK0000532082.HKD","LU0210533765.USD","GOOY","LU0642271901.SGD","HK0000304805.HKD","LU1221951046.USD","LU2362540622.SGD","VOX","LU0345769128.USD","LU1988902786.USD","IE000SO60NU8.SGD","HK0000304797.USD","SGXZ31699556.SGD","LU0077335932.USD","LU1145028129.USD","LU2092937148.SGD","IE0002270589.USD","LU0345769631.USD","BK4588","LU2750360641.GBP","IE00BYXW3230.USD","LU0823421333.USD","LU2403377893.USD","LU0109394709.USD","LU2168563687.JPY","LU0345770308.USD","LU0345774631.USD","LU1430594728.SGD","BK4534","LU1043141123.HKD","GXPC","LU2491049909.HKD","IE00B1BXHZ80.USD","GOOW","LU0149725797.USD","LU0354030511.USD","PTH","LU0426412945.USD","BBH","LU0215105999.USD","LU1267930813.SGD","LU0648000940.SGD","LU1496350502.SGD","LU0128525929.USD","LU2023250330.USD","LU0354030438.USD","LU0127658192.USD","LU0784384876.USD","LU1720051017.SGD","LU1670627923.USD","LU2362541273.HKD","LU0143551892.USD","LU0545039389.USD","IE00BMPRXR70.SGD","SG9999015341.SGD","LU0130518102.USD","LU0689626769.HKD","LU1852331112.SGD","LU2168564065.EUR","LU2462591350.SGD","BK4543","LU0310800965.SGD","LU2360106780.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU2602419157.SGD","LU0211328371.USD","IE00B19Z3B42.SGD","BK4566","IE0004086264.USD","LU0792757196.USD","LU1267930730.SGD","BK4514","LU2746668461.USD","LU0316494557.USD","LU2462157665.USD","BK4592","LU1323610961.USD","LU2077746001.SGD","LU0128525689.USD","LU1153585028.USD","LU1917777945.USD","LU2471134523.USD","LU2097344357.USD","LU0096362180.USD","LU2211815571.USD","LU1989772840.SGD","IE000WAW04H5.SGD","IE00BJLML261.HKD","IE00BMPRXQ63.HKD","LU0345774391.USD","LU0690374615.EUR","LU1244550577.SGD","LU0708995401.HKD","LU2471134879.HKD","LU2065171402.SGD","IE0001KFT4U8.USD","LU1815336760.USD","LU0276348264.USD","LU1868836757.USD","LU2456880835.USD","IE0009355771.USD","LU0070217475.USD","LU2746668974.SGD","LU0511384066.AUD","LU1951198990.SGD","IE00BJTD4V19.USD","SG9999018857.SGD","LU0069063385.USD","LU0476273544.USD","BK4139","LU2271345857.HKD","SG9999014880.SGD","LU2999663052.SGD","LU1400636574.HKD","LU0109391861.USD","LU2065170008.USD","LU2756315318.SGD","LU0130102774.USD","EFIV","LU0320765059.SGD","LU1585245621.USD","IE00BK4W5M84.HKD","LU0175139822.USD","LU2102340556.USD","LU0994945656.USD","LU1935042215.USD","BK4077","LU0158827781.USD","LU0528227936.USD","BK4602","IE00BJJMRZ35.SGD","LU2168564222.USD","LU0957808578.USD","LU2491050071.SGD","LU1244550494.USD","LU1868837300.USD","LU2860962120.EUR","SGXZ99366536.SGD","LU2756315664.SGD","LU0157215616.USD","LU2264538146.SGD","LU0265550359.USD","LU0211327993.USD","IE0000B7K699.USD","LU0096364046.USD","XDAT","ILDR","SG9999014559.SGD","LU1400636491.USD","LU2471134796.USD","LU2097829019.USD","IE00B1XK9C88.USD","LU1823568750.SGD","LU0070302665.USD","LU0158827948.USD","LU0267386448.USD","LU0820561818.USD","LU1366333091.USD","LU0353189763.USD","BK4581","LU0048584097.USD","BK4527","METV","LU2065171311.SGD","LU0889566641.SGD","LU2237438978.USD","BK4612","LU0052756011.USD","LU1670756490.USD","LU1121112475.USD","LU0310800379.SGD","LU1989764748.USD","LU1066053197.SGD","LU2054465674.USD","LU1923622614.USD","LU1201861165.SGD","LU2087625088.SGD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657646644","title":"8 ‘trendsetter’ stocks for world’s top mega-trends: Jon Erlichman","url":"https://stock-news.laohu8.com/highlight/detail?id=2657646644","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657646644?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:00","pubTimestamp":1786093200,"startTime":"0","endTime":"0","summary":"In the latest episode of Ticker Take, I spoke with Matt Orton of Raymond James Investment Management about that top-down approach, and the stocks he thinks fit it best.","market":"fut","thumbnail":"https://www.bnnbloomberg.ca/resizer/v2/ALRJGLKISQ5YQHT52J5GP2R3AQ.jpg?smart=true&auth=3cd1da2341d3279ac2053fa569f000b8d932710ca1ee4a201f166838db8d2c6d&width=500&height=333","type":0,"news_type":0,"thumbnails":["https://www.bnnbloomberg.ca/resizer/v2/ALRJGLKISQ5YQHT52J5GP2R3AQ.jpg?smart=true&auth=3cd1da2341d3279ac2053fa569f000b8d932710ca1ee4a201f166838db8d2c6d&width=500&height=333"],"rights":{"source":"bnn_bloomberg_highlight","url":"https://www.bnnbloomberg.ca/ticker-take/2026/08/07/8-trendsetter-stocks-for-worlds-top-mega-trends-jon-erlichman/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/ticker-take/2026/08/07/8-trendsetter-stocks-for-worlds-top-mega-trends-jon-erlichman/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["BK4553","CORO","MU","LU0056508442.USD","LU2211814178.USD","LU0820561818.USD","LU0264606111.USD","LU0642271901.SGD","EGGY","SGXZ99366536.SGD","VGT","BK4585","LU2360106947.USD","BK4129","BK4543","IE00BHPRN162.USD","LU2290526834.HKD","LU1037948897.HKD","LU2361044865.SGD","SGXZ51526630.SGD","GB00BDT5M118.USD","LU0127658192.USD","LU0471298694.HKD","LU1035775433.USD","IE00B19Z3B42.SGD","LU0965509101.SGD","TMED","LU1861215975.USD","SG9999018857.SGD","AIQ","LU0053671581.USD","ELIL","CGNG","AVSE","LU2236285917.USD","LU2324357040.USD","03145","LU0345770993.USD","LLY","LU0456855351.SGD","LLYX","THNR","LU0058720904.USD","IE00B19Z3581.USD","IE00BLSP4452.SGD","LU0320765059.SGD","LU2168564495.EUR","LU0006061336.USD","BK4554","LU2133065610.SGD","LU1127390331.HKD","LU2108987350.USD","LU0384037296.USD","LU0211328371.USD","BK4533","CURE","LU2860962120.EUR","PTF","LU2023251221.USD","LU1145028129.USD","LLYZ","IE00BJLML261.HKD","LU2756315664.SGD","MUYY","LU0203201768.USD","IE0002270589.USD","LU1983299246.USD","LU2931357623.SGD","LU2237443895.HKD","LU0096364046.USD","LU0889565833.HKD","LU2168564065.EUR","LU0648001328.SGD","LU2028103732.USD","LU0471298777.SGD","LU0198837287.USD","LU1934455194.USD","BK4550","LU0980610538.SGD","LU0353189763.USD","CHAT","HBMX","EMM","FXL","LU0234572021.USD","TSMX","LU2471134879.HKD","LU1023057109.AUD","LU0882747503.HKD","LU2063271972.USD","LU1720051108.HKD","BK4512","BK4581","LU2458330169.SGD","DRMY","BK4196","LU2089283258.USD","LU1571399168.USD","LU0757428866.USD","LU0792757196.USD","LU0823414551.USD","IE00BN29S564.USD","ARTY","LU0488056044.USD","LU2458330243.SGD","TRUH","BK4612","IE0004086264.USD","LU0143863784.USD","LU2264538146.SGD","HVAC","MEDI","LU2552382132.HKD","LU0211327993.USD","LU0786609619.USD","LU1989772840.SGD","LU2462157665.USD","LU0081259029.USD","SPWO","XLV","LU1914381329.SGD","SG9999018865.SGD","LU2250418816.HKD","LU2023250330.USD","IHE","IE00BD6J9T35.USD","XNTK","LU2102340556.USD","LU1232071149.USD","BOBP","LU1699723380.USD","LU2237443978.SGD","LU0079474960.USD","LU1917777945.USD","LU0225283273.USD","LU1803068979.SGD","LU1023059063.AUD","SG9999014880.SGD","CRDU","LU0122379950.USD","BAI","EFIV","LU2237443382.USD","IE00B4R5TH58.HKD","LU2357125470.USD","IE00BFSS7M15.SGD","IE0001KFT4U8.USD","KNOW","TSMG","LU0882574139.USD","LU1291159041.SGD","IE00B7KXQ091.USD","CGIC","AVEM","BK4591","LU2360108059.USD","LU2168564149.EUR","LU2361045086.USD","IE00BWXC8680.SGD","LU1506573853.SGD","LU0787776722.HKD","IE00BN8TJ469.HKD","LU0154236417.USD","LU0359201885.HKD","IE00B5TLWC47.USD","LU2125154935.USD","LU1282649810.SGD","LU1282649067.USD","LU2471134796.USD","LU2048586759.USD","LU2462591350.SGD","LU2506951792.HKD","LU1868837136.USD","LU0672654240.SGD","CNEQ","IE00BSNM7G36.USD","LU0061475181.USD","LU1934455863.HKD","LU2750360641.GBP","LU0820561909.HKD","LU2271345857.HKD","LU1508157978.USD","LU0541502299.USD","IE00BJJMRZ35.SGD","LU0964807845.USD","SG9999004220.SGD","LU1934455277.USD","LU1989771016.USD","LU2491049909.HKD","BK4602","LU0124676726.USD","LU1868837565.USD","OZEM","BTSG","LU1988902786.USD","LU1974910355.USD","LU2896262040.SGD","AIFD","LU0943347566.SGD","LU0385154629.USD","IE00BFXG1179.USD","LU2357305700.SGD","IE00BQXX3D17.EUR","SHOC","LU2360032135.SGD","XLK","LU2213496289.HKD","IE00B3M56506.USD","LU0175139822.USD","LU0130102774.USD","WDNA","IE0005OL40V9.USD","LU0082616367.USD","LU1093756168.USD","MUD","WUGI","IE00BK4W5L77.USD","MUU","TSMU","TSM","LU0256863811.USD","LU2023250504.SGD","LU0130517989.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0158827948.USD","LU0683600562.USD","BK4559","IXN","LU2417539215.USD","MEDX","USXF","LU0289960550.SGD","GDOC","LU1551013342.USD","LU2552382058.USD","LU0203347892.USD","CWI","IE00BQXX3F31.USD","STRL","LU0823421416.USD","LU0572940350.SGD","IE00BFXG0V08.USD","LU0256863902.USD","LU0541501648.USD","LU2663582299.SGD","SGXZ31699556.SGD","PPH","CANC","LU0823434740.USD","IE0004445015.USD","IE00BBT3K403.USD","BK4548","SG9999015952.SGD","SG9999014906.USD","LU1674673428.USD","SG9999015945.SGD","CRDO","LU1629891620.HKD","LU1868837722.USD","LU0882574055.USD","TSMZ","LU1989764748.USD","LU2265009873.SGD","LU2111349929.HKD","IE0009355771.USD","LU0689626769.HKD","LU0203345920.USD","LU0823414478.USD","LU0823416689.USD","BK","LU0203202063.USD","IE00B7SZLL34.SGD","IE0034235303.USD","LU1061106388.HKD","WDGF","BK4141","LU0109392836.USD","FHLC","EMC","IE00BFTCPJ56.SGD","LU0859254822.USD","SOXQ","TINS","LU2237443465.HKD","AIRR","IE00BKDWB100.SGD","RULE","JDOC","BK4516","LU2041044095.USD","IE00B1XK9C88.USD","PSCH","PSI","LU0965509283.SGD","LU1551013425.SGD","IE00B775H168.HKD","LU0689472784.USD","DISK","LU1712237335.SGD","LU1989764664.SGD","LU1267930730.SGD","LU0823421333.USD","LU0097036916.USD","LU1623119135.USD","ILDR","IXJ","LU2089985449.USD","LU0114720955.EUR","BK4532","IE00BJJMRX11.SGD","LHX","LU0878005551.USD","CGDG","IE00BFSS8Q28.SGD","BK4605","LU0109391861.USD","LU0174119429.USD","VHT","FTXH","LU2054465674.USD","LU0345770308.USD","LU1868838027.USD","SG9999001424.SGD","LU2357627491.SGD","LU1674673691.USD","BK4534","ADVE","LU1804176565.USD","LU1852331112.SGD","LU1868837300.USD","LU2543165471.USD","SMH","SG9999015986.USD","LU2361044949.HKD","LU0359202008.SGD","LU1720051017.SGD","AGNG","TTEQ","IE00BZ199S13.USD","IE00BK4W5M84.HKD","FTXL","LU0133085943.USD","BK4187","LU2746668461.USD","UMMA","LU1548497426.USD","LU0157215616.USD","LU0274383776.USD","LU0965508806.USD","LU2112291526.USD","LU1868836757.USD","SG9999001176.USD","LU2298321311.HKD","IE0009356076.USD","TEK","LU1316542783.SGD","LU2491050154.USD","SOXX","SG9999017495.SGD","IE0002141913.USD","ESIM","WLDR","LU0708995401.HKD","BK4599","LU2211815571.USD","LU2468319806.SGD","LU2471134952.CNY","FSPC","BK4588","LU1069344957.HKD","LU0823434583.USD","SG9999015978.USD","LU0354030511.USD","LU0314106906.USD","IE00B4JS1V06.HKD","BK4527","IE000M9KFDE8.USD","BK4135","IYH","LU1093756325.SGD","LU2471134523.USD","SG9999014898.SGD","LU2168564222.USD","LU0323591593.USD","MEMX","MIC","JGRO","LU0348723411.USD","TTXU","LU2360107168.USD","TSMY","LU1267930813.SGD","SG9999001176.SGD","MULL","LU2750360997.AUD","LU0353189680.USD","LU1778281490.HKD","LLII","BK4505","LU2602419157.SGD","LU2125154778.USD","LU2461242641.AUD","LU1868836591.USD","LU2552382215.SGD","IE00BLSP4239.USD","LU0289739699.SGD","LU2106854487.HKD","LU0572939691.SGD","LU2089984988.USD","LU0417517546.SGD","IE0009354923.USD","LU2237443549.SGD","FAI","BK4566","LU0878004406.USD","LU0320765992.SGD","LU0143863198.USD","PTH","LU0640476718.USD","LU0889566641.SGD","RXL","LU1323610961.USD","LU0719512351.SGD","LU0861579265.USD","LU2247934214.USD","PJP","LU0466842654.USD","LU2092937221.SGD","LU0158827781.USD","LU0820562030.AUD","LU0889565916.HKD","LU1280957306.USD","SG9999014914.USD","LU0266013472.USD","SG9999000418.SGD","BK4007","IE0004091025.USD","LU2756315318.SGD","LU1064131342.USD","LU1868836914.USD","LU2294711713.HKD","LU0072461881.USD","SGXZ57979304.SGD","LU2237438978.USD","BK4575","IE00BJT1NW94.SGD","LU1037948541.HKD","ELIS","CHPX","LU0238689110.USD","LU2456880835.USD","LU2491050071.SGD","ASIA","IE00B5949003.HKD","LU1979441026.SGD","LU2746668974.SGD","LU1366333091.USD","LU2360106780.USD","LU0477156953.USD","LU0006306889.USD","LU1057294990.SGD","LU2249611893.SGD","BK4526","EMSF","IE00BQXX3C00.GBP","MHIP","CGGO","LU1201861249.SGD","LU1861220033.SGD","LU2286300806.USD","BK4579","FDTX","LU0432979614.USD","SPTE","FTEC","AVXC","LU1815336091.USD","LU2168563687.JPY","LU0162691827.USD","LU2087625088.SGD","SG9999013999.USD","IE00B1BXHZ80.USD","LU0965509010.AUD","LU1366192091.USD","LU2065731478.USD","LU0359201612.USD","LU2237443622.USD","CHPS","IE00BYQQ9H92.USD","LU0354030438.USD","LU1211504680.USD","IETC","LU0316494557.USD","AIS","HRTS","LEGR","IE00BJJMRY28.SGD","TRFK","IE00BKPKM429.USD","BLOX","LU0310799852.SGD","LU1267930490.SGD","LU1989772923.USD","BK4503","MUZ","SGXZ81514606.USD","LU2403377893.USD","IE0004445239.USD","LU0094547139.USD","LU2089284900.SGD","LU0106261372.USD","LU1814569148.SGD","STSM","LU0210536198.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657718691","title":"Roivant Sciences Ltd : TD Cowen Raises Target Price to $50 from $41","url":"https://stock-news.laohu8.com/highlight/detail?id=2657718691","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657718691?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:05","pubTimestamp":1786082707,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN4440JG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","PTH","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169655769","title":"Dual Focus on Innovation and Global Expansion Drives Medical Device Sector Upgrades - ETF Tool Supports Recovery Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=1169655769","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169655769?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:42","pubTimestamp":1786063349,"startTime":"0","endTime":"0","summary":"The medical device sector, which has faced significant pressure in recent years, is now poised for a turning point. This shift is driven by a systemic optimization of healthcare industry policies,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","AGNG","PTH","BK1100","CZA","HART","LNGR","RSPH","159898","GDOC","IEIH","LCO","LGHT","MDEV","159891","159883","MEDX","BK1583","BK1574","NIFE","REVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652347","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652347","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652347?lang=en_us&edition=fundamental","pubTime":"2026-08-07 03:30","pubTimestamp":1786044629,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Roivant Sciences (ROIV), Opus Genetics (IRD) and Reg...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-283?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-283?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRD","PTH","BK4007","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657658768","title":"Bernstein Remains a Hold on Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657658768","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657658768?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:01","pubTimestamp":1786028493,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jeffrey Walch from Bernstein maintained a Hold rating on Revolution Medicines, with a price target of $151.00. Walc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-revolution-medicines-rvmd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-revolution-medicines-rvmd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","BBH","IDNA","IE00BJT1NW94.SGD","LU0109394709.USD","LU0889565916.HKD","CANC","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0009355771.USD","IE0002141913.USD","BK4139","IE0009354923.USD","IE00BFTCPJ56.SGD","PTH","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657632462","title":"Roivant Sciences Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657632462","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657632462?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:32","pubTimestamp":1786023131,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd reports results for the quarter ended June 30 - Earnings SummaryRoivant Sciences LtdROIV.OQreported a quarterly adjusted loss of 26 cents per share for the quarter ended June 30, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4431W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","PTH","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657632405","title":"Immunovant, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657632405","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657632405?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:32","pubTimestamp":1786023121,"startTime":"0","endTime":"0","summary":"Immunovant, Inc. reports results for the quarter ended June 30 - Earnings SummaryImmunovant, Inc.IMVT.OQreported a quarterly adjusted loss of 75 cents per share for the quarter ended June 30, lower th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4431VO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4007","BK4588","ROIV","PTH","BK4139","IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639266","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Revolution Medicines (RVMD), Royalty Pharma (RPRX) and Urogen Pharma (URGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639266?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:10","pubTimestamp":1786018244,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Revolution Medicines (RVMD), Royalty Pharma (RPRX) and Urogen Pha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-revolution-medicines-rvmd-royalty-pharma-rprx-and-urogen-pharma-urgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-revolution-medicines-rvmd-royalty-pharma-rprx-and-urogen-pharma-urgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","IE00B4R5TH58.HKD","IDNA","IE00BJJMRZ35.SGD","XLV","LU0320765992.SGD","HCSG","LU0128526141.USD","IE00B2B36J28.USD","PBE","LABU","IE00BJT1NW94.SGD","XBI","BK4585","IHE","IE0009354923.USD","BK4137","BK4007","LU0889565916.HKD","BK4581","CANC","RVMD","BBH","RPRX","IE0009355771.USD","PTH","IE00BFTCPJ56.SGD","LU0029874061.USD","URGN","LU0109394709.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657163591","title":"Roivant Sciences' Fiscal Q1 Net Loss Narrows, Revenue Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2657163591","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657163591?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:40","pubTimestamp":1786016421,"startTime":"0","endTime":"0","summary":"Roivant Sciences  reported a fiscal Q1 net loss Thursday of $0.26 per diluted share, narrowing from a loss of $0.33 per share a year earlier.Four analysts polled by FactSet expected a loss of $0.33 per share.Revenue for the quarter ended June 30 was $1.4 million, compared with $2.2 million a year earlier.Analysts expected $2.1 million.Shares of Roivant Sciences were up more than 1% premarket Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ROIV","PTH","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657335626","title":"Immunovant FY27 Q1 Net Loss Widens 27% to $153.2 Million; R&D Expenses Rise 40.9% to $142.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657335626","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657335626?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:20","pubTimestamp":1786015233,"startTime":"0","endTime":"0","summary":"Immunovant FY27 Q1 net loss widens 27% to $153.2 million; R&D expenses rise 40.9% to $142.6 millionImmunovant posted a wider net loss of USD 153.2 million, or USD 0.75 a share, for the quarter ended J","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDLnH5Br:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","PTH","BK4139","BK4007","IMVT","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638786","title":"Roivant Sciences Q1 Adj. EPS $(0.34) Misses $(0.32) Estimate, Sales $1.442M Miss $2.057M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638786","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638786?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:12","pubTimestamp":1786014730,"startTime":"0","endTime":"0","summary":"Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.32) by 6.25 percent. This is a 36 percent decrease over losses of $(0.25) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60988265/roivant-sciences-q1-adj-eps-0-34-misses-0-32-estimate-sales-1-442m-miss-2-057m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PTH","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657198638","title":"Roivant Unit Priovant Begins Phase 3 Beacon+ Trial of Brepocitinib in Cutaneous Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2657198638","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657198638?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:07","pubTimestamp":1786014437,"startTime":"0","endTime":"0","summary":"Roivant unit Priovant begins Phase 3 BEACON+ trial of brepocitinib in cutaneous sarcoidosisRoivant unit Priovant enrolled first patients in a Phase 3 trial of brepocitinib for cutaneous sarcoidosis, a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL4GgQ86:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","PTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638191","title":"Roivant Q1 FY27 Net Loss Widens to $290.61 Million; Revenue Slips to $1.44 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638191","media":"Reuters","labels":["shareholding","policyRegulatory","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638191?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:07","pubTimestamp":1786014430,"startTime":"0","endTime":"0","summary":"Roivant Q1 FY27 net loss widens to $290.61 million; revenue slips to $1.44 millionRoivant posted a GAAP net loss of USD 290.61 million, widening from USD 273.91 million a year earlier; GAAP loss per s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL9Ngwhl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,policyRegulatory,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","BK4548","ROIV","BK4139","MRNX","BK4533","WDNA","MRNY","BK4585","BK4588","GNOM","BK4534","BK4501","BK4568","IDNA","BK4551","LGHT","MRNA","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638810","title":"Roivant Sciences Q1 Adjusted Net Income USD -290.606 Million Vs. IBES Estimate USD -192.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638810","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638810?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:01","pubTimestamp":1786014062,"startTime":"0","endTime":"0","summary":"BRIEF-Roivant Sciences Q1 Adjusted Net Income USD -290.606 Million Vs. IBES Estimate USD -192.3 MillionAug 06  - Roivant Sciences Q1 revenue USD 1.442 million.Q1 net income USD -290.606 millionQ1 pretax profit USD -294.564 million vs. IBES estimate USD -243.7 millionQ1 basic EPS USD -0.26Q1 income from operations USD -365.993 million vs. IBES estimate USD -306.8 millionQ1 operating expenses USD 367.827 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXNPHVMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PTH","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657633601","title":"Roivant Sciences - Brepocitinib Nda Approval and Launch in Dermatomyositis Expected by End of September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2657633601","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657633601?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA7TZ9FK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ROIV","BK4139","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657899596","title":"Revolution Medicines, Inc. : Needham Raises Target Price to $240 from $236","url":"https://stock-news.laohu8.com/highlight/detail?id=2657899596","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657899596?lang=en_us&edition=fundamental","pubTime":"2026-08-06 17:10","pubTimestamp":1786007401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN44313L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","RVMD","CANC","LU0320765992.SGD","IE0009355771.USD","IE0009354923.USD","BBH","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","PTH","BK4139","IE00B2B36J28.USD","LU0889565916.HKD","IDNA","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657571976","title":"Revolution Medicines Publishes Corporate Deck Outlining Ras(on) Inhibitor Pipeline Targeting RAS-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657571976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657571976?lang=en_us&edition=fundamental","pubTime":"2026-08-06 06:01","pubTimestamp":1785967310,"startTime":"0","endTime":"0","summary":"Revolution Medicines publishes corporate deck outlining RAS(ON) inhibitor pipeline targeting RAS-driven cancersRevolution Medicines highlighted Phase 3 RASolute 302 data in previously treated metastat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL65Wkg4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IDNA","IE00B4R5TH58.HKD","BBH","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","CANC","IE0009354923.USD","IE0009355771.USD","PTH","IE00BJJMRZ35.SGD","LU0109394709.USD","RVMD","LU0320765992.SGD","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657726576","title":"Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657726576","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657726576?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:11","pubTimestamp":1785964302,"startTime":"0","endTime":"0","summary":"Guardant Health director Ian T. Clark disposes of common shares worth $2.25 millionGuardant Health director Ian T. Clark reported option exercises on Aug. 4, 2026, acquiring 9,088 common shares at USD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL7mNXxZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GNOM","GDOC","BK4535","BK4551","LU0320765992.SGD","PTH","EKG","GH","BK4196","GNMX","LU0109394709.USD","BK4585","LU0889565916.HKD","HELX","FFOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657576322","title":"Revolution Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657576322","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657576322?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:01","pubTimestamp":1785963706,"startTime":"0","endTime":"0","summary":"Revolution Medicines, Inc. reports results for the quarter ended June 30 - Earnings SummaryRevolution Medicines, Inc.RVMD.OQreported a quarterly adjusted loss of $3.06 per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4423HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","IDNA","IE00B2B36J28.USD","BBH","LU0889565916.HKD","IE00B4R5TH58.HKD","PTH","RVMD","IE0002141913.USD","IE0009355771.USD","IE0009354923.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0109394709.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}